Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Feb;72(2):1231-8.
doi: 10.1128/AEM.72.2.1231-1238.2006.

Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies

Affiliations

Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies

Shashi K Sharma et al. Appl Environ Microbiol. 2006 Feb.

Abstract

An amplified enzyme-linked immunosorbent assay (ELISA) for the detection of Clostridium botulinum complex neurotoxins was evaluated for its ability to detect these toxins in food. The assay was found to be suitable for detecting type A, B, E, and F botulinum neurotoxins in a variety of food matrices representing liquids, solid, and semisolid food. Specific foods included broccoli, orange juice, bottled water, cola soft drinks, vanilla extract, oregano, potato salad, apple juice, meat products, and dairy foods. The detection sensitivity of the test for these botulinum complex serotypes was found to be 60 pg/ml (1.9 50% lethal dose [LD50]) for botulinum neurotoxin type A (BoNT/A), 176 pg/ml (1.58 LD50) for BoNT/B, 163 pg/ml for BoNT/E (4.5 LD50), and 117 pg/ml for BoNT/F (less than 1 LD50) in casein buffer. The test could also readily detect 2 ng/ml of neurotoxins type A, B, E, and F in a variety of food samples. For specificity studies, the assay was also used to test a large panel of type A C. botulinum, a smaller panel of proteolytic and nonproteolytic type B, E, and F neurotoxin-producing Clostridia, and nontoxigenic organisms using an overnight incubation of toxin production medium. The assay appears to be an effective tool for large-scale screening of the food supply in the event of a botulinum neurotoxin contamination event.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Standard curve for the four botulinum neurotoxin complex serotypes in casein buffer. (A) Standard curve for BoNT/A, BoNT/B, BoNT/E, and BoNT/F. Points represent the mean absorbance values of duplicate wells. Where not visible, the error bars are within the symbol. (B) Relationship between mouse LD50 and concentration.
FIG. 2.
FIG. 2.
The ELISA determinations of 2 ng/ml BoNT/A (A) and BoNT/B (B) complexes in food samples. The samples were spiked with neurotoxin complex and incubated at 30 min at room temperature. The absorbance of the negative food sample controls was subtracted from the positive food sample absorbance. The toxin extraction procedures are given in Materials and Methods.
FIG. 3.
FIG. 3.
The ELISA determinations of 2 ng/ml BoNT/E (A) and BoNT/F (B) complexes in food samples. The samples were spiked with neurotoxin complex and incubated for 30 min at room temperature. The absorbance of the negative food sample controls was subtracted from the positive food sample absorbance. The toxin extraction procedures are given in Materials and Methods.

Similar articles

Cited by

References

    1. Andreadis, J. D., J. J. Kools, J. K. Dykes, and J. L. Ferreira, and S. E. Maslanka. 2003. Development of an in vitro DIG-ELISA assay for detection of Clostridium botulinum neurotoxin serotype A, B, E and F, abstr. 56. In Future directions for biodefense research: development of countermeasures. Proceedings of the ASM Biodefense Research Meeting. American Society for Microbiology, Washington, D.C.
    1. Arnon, S. S., R. Schechter, T. V. Inglesby, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, J. Hauer, M. Layton, S. Lillibridge, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, D. L. Swerdlow, and K. Tonat. 2001. Botulinum toxin as a biological weapon: medical and public health management. JAMA 285:1059-1070. - PubMed
    1. Binz, T., H. Kurazono, M. Wille, J. Frevert, K. Wernars, and H. Niemann. 1990. The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins. J. Biol. Chem. 265:9153-9158. - PubMed
    1. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254. - PubMed
    1. Burkard, F., F. Chen, G. M. Kuziemko, and R. C. Stevens. 1997. Electron density projection map of the botulinum neurotoxin 900-kilodalton complex by electron crystallography. J. Struct. Biol. 120:78-84. - PubMed

MeSH terms

LinkOut - more resources